Edition:
United States

People: Protalix Biotherapeutics Inc (PLX)

PLX on American Stock Exchange

0.71USD
21 Nov 2017
Change (% chg)

$0.05 (+6.72%)
Prev Close
$0.67
Open
$0.69
Day's High
$0.74
Day's Low
$0.69
Volume
1,917,780
Avg. Vol
1,011,706
52-wk High
$1.51
52-wk Low
$0.26

Bronfeld, Zeev 

Mr. Zeev Bronfeld has been appointed as an Independent Director of Protalix Biotherapeutics. Mr. Bronfeld has served as a director of Protalix Ltd. since 1996 and as our director since December 2006. Mr. Bronfeld brings to us vast experience in management and value building of biotechnology companies. He is an experienced businessman who is involved in a number of biotechnology companies. He was a co-founder of Biocell Ltd., a former Israeli publicly-traded holding company that specialized in biotechnology companies and served as its Chief Executive Officer from 1986 through 2015. Mr. Bronfeld currently serves as a director of The Trendlines Group (SGX:42T) and D.N.A. Biomedical Solutions Ltd. (DNA:TASE), both of which are public companies. Mr. Bronfeld is also a director of a number of privately-held companies, most of which are involved in the life sciences, such as Entera Bio Ltd., Contipi Medical Ltd. and TransBiodiesel Ltd. From 2008 through January 2017, Mr. Bronfeld served as a director of Macrocure Ltd., a Nasdaq-listed company that merged into Leap Therapeutics, Inc. (NASDAQ:LPTX), and from 2004 through 2012, Mr. Bronfeld served as a director of D. Medical Industries Ltd., a company that was dually-listed on the Nasdaq and the TASE. Mr. Bronfeld received a B.A. in Economics from the Hebrew University in 1975. We believe Mr. Bronfeld’s qualifications to serve on our Board of Directors include his years of experience in the management of private and public Israeli companies, including life science companies.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Shlomo Yanai

--

Moshe Manor

205,733

Yossi Maimon

859,997

Tzvi Palash

482,763

Yoseph Shaaltiel

775,897

Einat Almon

678,820
As Of  30 Dec 2014